This Static Spot is open for sponsor

Click Here to Sponsor MCT Eric Post in Full Page

Afrikaans Afrikaans Albanian Albanian Amharic Amharic Arabic Arabic Armenian Armenian Azerbaijani Azerbaijani Basque Basque Belarusian Belarusian Bengali Bengali Bosnian Bosnian Bulgarian Bulgarian Catalan Catalan Cebuano Cebuano Chichewa Chichewa Chinese (Simplified) Chinese (Simplified) Chinese (Traditional) Chinese (Traditional) Corsican Corsican Croatian Croatian Czech Czech Danish Danish Dutch Dutch English English Esperanto Esperanto Estonian Estonian Filipino Filipino Finnish Finnish French French Frisian Frisian Galician Galician Georgian Georgian German German Greek Greek Gujarati Gujarati Haitian Creole Haitian Creole Hausa Hausa Hawaiian Hawaiian Hebrew Hebrew Hindi Hindi Hmong Hmong Hungarian Hungarian Icelandic Icelandic Igbo Igbo Indonesian Indonesian Irish Irish Italian Italian Japanese Japanese Javanese Javanese Kannada Kannada Kazakh Kazakh Khmer Khmer Korean Korean Kurdish (Kurmanji) Kurdish (Kurmanji) Kyrgyz Kyrgyz Lao Lao Latin Latin Latvian Latvian Lithuanian Lithuanian Luxembourgish Luxembourgish Macedonian Macedonian Malagasy Malagasy Malay Malay Malayalam Malayalam Maltese Maltese Maori Maori Marathi Marathi Mongolian Mongolian Myanmar (Burmese) Myanmar (Burmese) Nepali Nepali Norwegian Norwegian Pashto Pashto Persian Persian Polish Polish Portuguese Portuguese Punjabi Punjabi Romanian Romanian Russian Russian Samoan Samoan Scottish Gaelic Scottish Gaelic Serbian Serbian Sesotho Sesotho Shona Shona Sindhi Sindhi Sinhala Sinhala Slovak Slovak Slovenian Slovenian Somali Somali Spanish Spanish Sundanese Sundanese Swahili Swahili Swedish Swedish Tajik Tajik Tamil Tamil Telugu Telugu Thai Thai Turkish Turkish Ukrainian Ukrainian Urdu Urdu Uzbek Uzbek Vietnamese Vietnamese Welsh Welsh Xhosa Xhosa Yiddish Yiddish Yoruba Yoruba Zulu Zulu

 

 

Article Navigation

Back To Main Page

 

Click Here for more articles
Google
Prempro Breast Cancer Risks
by: Michael@Monheit.com - Michael Monheit, Esquir
While Prempro may cure your hot flashes, it may also debilitate or kill you from ovarian cancer, breast cancer, endometrial cancer, and stroke.

Since 1995, millions of women have confidently taken Prempro, a leading hormone replacement therapy drug, prescribed to treat postmenopausal hot flashes and other menopausal symptoms.

However, a recent major study concludes that long-term use of Prempro has significantly increased the risk of stroke, blood clots, Prempro ovarian cancer, endometrial cancer, and breast cancer, while maximizing the risk for dementia and Alzheimer’s disease. Evidence has revealed that Prempro and other estrogen progestin combinations can actually harm perfectly healthy women.

These results were found in the nation's largest hormone replacement study and were so alarming that the National Institute of Health (NIH) prematurely canceled the study citing risk to the participants. As a result the study is suggesting that many of the women who use Prempro and other estrogen and progestin combinations should quit and talk to their doctors about Prempro alternatives.

Prempro is manufactured by Wyeth Pharmaceuticals. In 2001 Prempro accounted for approximately $890 million of the company's $13.9 billion in sales.

Monheit Law is investigating Prempro Cancer cases for long term users of Prempro who have developed either breast or ovarian cancer.

See: http://www.monheit.com/prempro/problem.shtml for the original text of this article.

About the Author

Monheit Law is investigating Prempro Cancer cases for long term users of Prempro who have developed either breast or ovarian cancer.

 


©2005 - All Rights Reserved

This Static Spot is open for sponsor

JV Blogs Visit free hit counter